Esperion Therapeutics Inc (ESPR)

Jan 29, 2025

Esperion Therapeutics chief commercial officer sells $277 in stock - MSN

Jan 29, 2025

Jan 27, 2025

What is HC Wainwright’s Estimate for ESPR FY2028 Earnings? - Defense World

Jan 27, 2025

Jan 26, 2025

Esperion Therapeutics’ (ESPR) Buy Rating Reiterated at HC Wainwright - Defense World

Jan 26, 2025

Jan 25, 2025

JMP Securities maintains $7 target on Esperion stock - MSN

Jan 25, 2025

Jan 23, 2025

JMP Securities maintains $7 target on Esperion stock By Investing.com - Investing.com Canada

Jan 23, 2025

Jan 23, 2025

Esperion Therapeutics' (ESPR) "Market Outperform" Rating Reiterated at JMP Securities - MarketBeat

Jan 23, 2025

Jan 23, 2025

HC Wainwright Reiterates Buy Rating for Esperion Therapeutics (NASDAQ:ESPR) - MarketBeat

Jan 23, 2025

Jan 23, 2025

Equities Analysts Set Expectations for ESPR FY2025 Earnings - MarketBeat

Jan 23, 2025

Jan 23, 2025

Cantor Fitzgerald Comments on ESPR FY2025 Earnings - Defense World

Jan 23, 2025

Jan 21, 2025

Esperion Therapeutics chief commercial officer sells $277 in stock By Investing.com - Investing.com Australia

Jan 21, 2025

Jan 21, 2025

Esperion Therapeutics CFO sells shares worth $20 By Investing.com - Investing.com South Africa

Jan 21, 2025

Jan 21, 2025

Esperion Therapeutics CFO sells shares worth $20 - Investing.com India

Jan 21, 2025

Jan 19, 2025

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Short Interest Update - MarketBeat

Jan 19, 2025

Jan 18, 2025

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Stock Position Lifted by Barclays PLC - Defense World

Jan 18, 2025

Jan 18, 2025

Barclays PLC Grows Position in Esperion Therapeutics, Inc. (NASDAQ:ESPR) - MarketBeat

Jan 18, 2025

Jan 17, 2025

Esperion stock falls on higher operating expense forecast - MSN

Jan 17, 2025

Jan 15, 2025

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives $7.30 Consensus Target Price from Analysts - Defense World

Jan 15, 2025

Jan 12, 2025

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Jan 12, 2025

Jan 10, 2025

Esperion Therapeutics' (ESPR) Buy Rating Reiterated at HC Wainwright - MarketBeat

Jan 10, 2025

Jan 09, 2025

IMTX: 3 Small-Cap Healthcare Stocks With Big Upside Potential - StockNews.com

Jan 09, 2025

Jan 09, 2025

Esperion to Host Virtual Key Opinion Leader Event on Wednesday, January 22, 2025, at 11:30 a.m. ET. - The Manila Times

Jan 09, 2025

Jan 09, 2025

Esperion to Host KOL Event on NEXLETOL, NEXLIZET Real-World Impact in Cholesterol Management - StockTitan

Jan 09, 2025

Jan 08, 2025

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2024 Earnings Call Transcript - MSN

Jan 08, 2025

Jan 04, 2025

Geode Capital Management LLC Acquires 171,609 Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR) - Defense World

Jan 04, 2025

Jan 03, 2025

Best 5 Penny Stocks With Great Financial Health (January 2025) - Investing.com

Jan 03, 2025

Jan 02, 2025

Esperion to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference - The Bakersfield Californian

Jan 02, 2025

Jan 02, 2025

Esperion to Present at J.P. Morgan Healthcare Conference: Showcasing Non-Statin Breakthroughs - StockTitan

Jan 02, 2025

Dec 31, 2024

FINAL DEADLINE ALERT: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against Esperion Therapeutics, Inc. and Encourages Investors with Losses in Excess of $250,000 to Immediately Contact the Firm - AccessWire

Dec 31, 2024

Dec 29, 2024

Short Interest in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Decreases By 16.5% - MarketBeat

Dec 29, 2024

Dec 26, 2024

ZTS: 3 Healthcare Innovators with Analyst-Endorsed Upside - StockNews.com

Dec 26, 2024

Dec 21, 2024

Public Employees Retirement System of Ohio Buys New Position in Esperion Therapeutics, Inc. (NASDAQ:ESPR) - MarketBeat

Dec 21, 2024

Dec 20, 2024

ESPREsperion Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Dec 20, 2024

Dec 20, 2024

Wellington Management Group LLP Grows Stock Holdings in Esperion Therapeutics, Inc. (NASDAQ:ESPR) - MarketBeat

Dec 20, 2024

Dec 20, 2024

Analysts Set Expectations for ESPR FY2024 Earnings - Defense World

Dec 20, 2024

Dec 19, 2024

Cantor Fitzgerald Estimates ESPR FY2024 Earnings - MarketBeat

Dec 19, 2024

Dec 19, 2024

FOLD: 3 High-Growth Biotech Stocks to Watch - StockNews.com

Dec 19, 2024

Dec 19, 2024

Esperion Therapeutics CFO Benjamin Halladay sells $7,865 in stock By Investing.com - Investing.com Canada

Dec 19, 2024

Dec 18, 2024

Esperion Therapeutics CFO Benjamin Halladay sells $7,865 in stock - Investing.com India

Dec 18, 2024

Dec 18, 2024

Cantor Fitzgerald Initiates Coverage of Esperion Therapeutics (ESPR) with Overweight Recommendation - MSN

Dec 18, 2024

Dec 18, 2024

Esperion Therapeutics issues $100M in new convertible notes - Investing.com

Dec 18, 2024

Dec 18, 2024

Esperion Therapeutics issues $100M in new convertible notes By Investing.com - Investing.com UK

Dec 18, 2024

Dec 18, 2024

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 18, 2024

Dec 18, 2024

Esperion Therapeutics (NASDAQ:ESPR) Coverage Initiated by Analysts at The Goldman Sachs Group - MarketBeat

Dec 18, 2024